M. Koot

2.0k total citations · 1 hit paper
21 papers, 1.6k citations indexed

About

M. Koot is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, M. Koot has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 13 papers in Virology and 8 papers in Epidemiology. Recurrent topics in M. Koot's work include HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). M. Koot is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). M. Koot collaborates with scholars based in Netherlands, Slovakia and Bahrain. M. Koot's co-authors include M Tersmette, Hanneke Schuitemaker, Neeltje A. Kootstra, Frank Miedema, Jan Karel M. Eeftinck Schattenkerk, Joep M. A. Lange, R E de Goede, Reindert P. van Steenwijk, Frank Miedema and R. E. Y. de Goede and has published in prestigious journals such as Journal of Virology, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

M. Koot

21 papers receiving 1.6k citations

Hit Papers

Biological phenotype of human immunodeficiency virus type... 1992 2026 2003 2014 1992 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
    1992 874 citations Hanneke Schuitemaker, M. Koot et al. Journal of Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Koot Netherlands 13 1.4k 892 722 336 151 21 1.6k
Maarten Koot Netherlands 17 1.7k 1.2× 1.2k 1.3× 684 0.9× 494 1.5× 202 1.3× 20 2.0k
Mary N. Phillips United States 7 1.3k 1.0× 699 0.8× 835 1.2× 325 1.0× 181 1.2× 7 1.5k
Theresa Flynn United States 12 1.1k 0.8× 509 0.6× 807 1.1× 412 1.2× 196 1.3× 15 1.6k
Timothy Brennan United States 13 1.1k 0.8× 969 1.1× 367 0.5× 390 1.2× 119 0.8× 18 1.5k
J J de Jong Netherlands 12 1.3k 0.9× 887 1.0× 402 0.6× 250 0.7× 232 1.5× 15 1.4k
Theresa Shea United States 7 1.3k 0.9× 847 0.9× 592 0.8× 300 0.9× 136 0.9× 8 1.4k
H G Huisman Netherlands 7 1.5k 1.1× 945 1.1× 592 0.8× 253 0.8× 222 1.5× 8 1.6k
Pierre Versmisse France 19 1.4k 1.0× 576 0.6× 968 1.3× 416 1.2× 133 0.9× 28 1.7k
Mary Fran McLane United States 19 1.0k 0.7× 616 0.7× 641 0.9× 294 0.9× 208 1.4× 29 1.5k
Åsa Björndal Sweden 16 1.9k 1.4× 1.2k 1.3× 940 1.3× 336 1.0× 383 2.5× 24 2.2k

Countries citing papers authored by M. Koot

Since Specialization
Citations

This map shows the geographic impact of M. Koot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Koot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Koot more than expected).

Fields of papers citing papers by M. Koot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Koot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Koot. The network helps show where M. Koot may publish in the future.

Co-authorship network of co-authors of M. Koot

This figure shows the co-authorship network connecting the top 25 collaborators of M. Koot. A scholar is included among the top collaborators of M. Koot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Koot. M. Koot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khalifeh, Masoomeh, et al.. (2024). RNA-based logic for selective protein expression in senescent cells. The International Journal of Biochemistry & Cell Biology. 174. 106636–106636. 1 indexed citations
2.
Koot, Hans M., Boris M. Hogema, M. Koot, Michel Molier, & Hans L. Zaaijer. (2014). Frequent hepatitis E in the Netherlands without traveling or immunosuppression. Journal of Clinical Virology. 62. 38–40. 31 indexed citations
3.
Takkenberg, R. Bart, A. de Niet, Hans L. Zaaijer, et al.. (2013). 753 BASELINE HBsAg PREDICTS HBsAg LOSS AFTER 2 YEARS OF TREATMENT-FREE FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND ADEFOVIR. Journal of Hepatology. 58. S305–S305. 3 indexed citations
4.
Niet, A. de, R. Bart Takkenberg, Ryma Benayed, et al.. (2012). Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir. Scandinavian Journal of Gastroenterology. 47(4). 475–481. 29 indexed citations
5.
Zaaijer, Hans L., P.N. Lelie, Christina M. J. E. Vandenbroucke‐Grauls, & M. Koot. (2002). Concurrence of hepatitis B surface antibodies and surface antigen: implications for postvaccination control of health care workers. Journal of Viral Hepatitis. 9(2). 146–148. 8 indexed citations
6.
Koot, M., R. E. Y. de Goede, Ireneus P.M. Keet, et al.. (1999). Conversion Rate towards a Syncytium‐Inducing (SI) Phenotype during Different Stages of Human Immunodeficiency Virus Type 1 Infection and Prognostic Value of SI Phenotype for Survival after AIDS Diagnosis. The Journal of Infectious Diseases. 179(1). 254–258. 82 indexed citations
7.
Messele, Tsehaynesh, Mohammed Baba Abdulkadir, Arnaud Fontanet, et al.. (1999). Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clinical & Experimental Immunology. 115(3). 443–450. 96 indexed citations
8.
Bruisten, Sylvia M., P. H. J. Frissen, Peter van Swieten, et al.. (1997). Prospective Longitudinal Analysis of Viral Load and Surrogate Markers in Relation to Clinical Progression in HIV Type 1-Infected Persons. AIDS Research and Human Retroviruses. 13(4). 327–335. 26 indexed citations
9.
Koot, M., R. van Leeuwen, R. E. Y. de Goede, et al.. (1997). Conversion rate towards a syncytium inducing (SI) phenotype during different stages of HIV infection and prognostic value of SI phenotype for survival after aids diagnoses. Immunology Letters. 56. 125–126. 1 indexed citations
10.
Koot, M., Angélique B. van ’t Wout, Neeltje A. Kootstra, et al.. (1996). Relation between Changes in Cellular Load, Evolution of Viral Phenotype, and the Clonal Composition of Virus Populations in the Course of Human Immunodeficiency Virus Type 1 Infection. The Journal of Infectious Diseases. 173(2). 349–354. 118 indexed citations
11.
Miedema, Frank, et al.. (1995). T Cell Function In Vitro Is An Independent Progression Marker For Aids In Human Immunodeficiency Virus-Infected Asymptomatic Subjects. The Journal of Infectious Diseases. 171(3). 531–536. 68 indexed citations
12.
Jurriaans, Suzanne, Gerrit‐Jan Weverling, Jaap Goudsmit, et al.. (1995). Distinct Changes in HIV Type 1 RNA versus p24 Antigen Levels in Serum during Short-Term Zidovudine Therapy in Asymptomatic Individuals with and without Progression to AIDS. AIDS Research and Human Retroviruses. 11(4). 473–479. 20 indexed citations
13.
Schellekens, P T, et al.. (1995). Immunologic and virologic markers determining progression to AIDS.. PubMed. 10 Suppl 2. S62–6. 9 indexed citations
14.
Keet, Ireneus P.M., Anneke Krol, Michèl R. Klein, et al.. (1994). Characteristics of Long-Term Asymptomatic Infection with Human Immunodeficiency Virus Type 1 in Men with Normal and Low CD4+ Cell Counts. The Journal of Infectious Diseases. 169(6). 1236–1243. 77 indexed citations
15.
Klein, Michèl R., Ireneus P.M. Keet, J. D’Amaro, et al.. (1994). Associations between HLA Frequencies and Pathogenic Features of Human Immunodeficiency Virus Type 1 Infection in Seroconverters from the Amsterdam Cohort of Homosexual Men. The Journal of Infectious Diseases. 169(6). 1244–1249. 90 indexed citations
16.
Schellekens, P T, et al.. (1994). Immunological and virological markers determining progression to AIDS.. PubMed. 45(6). 238–43. 1 indexed citations
17.
Koot, M., P. T. A. Schellekens, Jan W. Mulder, et al.. (1993). Viral Phenotype and T Cell Reactivity in Human Immunodeficiency Virus Type 1-Infected Asymptomatic Men Treated with Zidovudine. The Journal of Infectious Diseases. 168(3). 733–736. 46 indexed citations
18.
Schuitemaker, Hanneke, M. Koot, Neeltje A. Kootstra, et al.. (1992). Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. Journal of Virology. 66(3). 1354–1360. 874 indexed citations breakdown →
19.
Ronde, Anthony de, C. J. A. Sol, Marcy E. MacDonald, et al.. (1987). Two Domains within the Early Coding Region of SV40 Involved in the Transformation of Human Fibroblasts. Intervirology. 28(4). 221–231. 2 indexed citations
20.
Aerts, Johannes M. F. G., Wilma E. Donker‐Koopman, M. Koot, et al.. (1986). Comparison of the properties of a soluble form of glucocerebrosidase from human urine with those of the membrane-associated tissue enzyme. Biochimica et Biophysica Acta (BBA) - Biomembranes. 863(1). 63–70. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maarten Koot Breakdown of academic impact, for papers by Mary N. Phillips Breakdown of academic impact, for papers by Theresa Flynn Breakdown of academic impact, for papers by Timothy Brennan Breakdown of academic impact, for papers by J J de Jong Breakdown of academic impact, for papers by Theresa Shea Breakdown of academic impact, for papers by H G Huisman Breakdown of academic impact, for papers by Pierre Versmisse Breakdown of academic impact, for papers by Mary Fran McLane Breakdown of academic impact, for papers by Åsa Björndal
Rankless by CCL
2026